GLP-1 clinical trials in Oklahoma: 12 recruiting now
14 sites in 4 Oklahoma cities. Registry checked October 2, 2026.
Screening for a study can take weeks. The cheapest program today is Strut Health.
No insurance needed.
- Strut Health$149 a month, with auto-refillcompounded semaglutideCheck price →You pick Weight Loss, then a five-minute online visit
- Shed$199 a month30% off first month with code Shed10compounded semaglutideCheck price →A health form first, then you choose your plan
Weight-loss studies (5)
Weight-loss study of cagrisema
Where: Norman
What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lose weight.
Free to join
Who can join: Adults 18+ with obesity, BMI 35+.
Study record on ClinicalTrials.gov
Alliance for Multispecialty Research, Norman
Lynn Institute of Norman, Norman
Weight-loss study of maridebart cafraglutide
Where: Chickasha and Oklahoma City
What: Tests whether a study medicine from Amgen, Maridebart Cafraglutide, can help people lose weight.
Free to join
Who can join: Adults 18+ with obesity or overweight, BMI 25+.
Study record on ClinicalTrials.gov
Epic Medical Research - Oklahoma, Chickasha
Lynn Health Science Institute, Oklahoma City
Weight-loss study of orforglipron
Where: Oklahoma City
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.
Free to join
Who can join: Children and teens 6 to 17 with obesity.
Study record on ClinicalTrials.gov
University of Oklahoma Health Sciences Center, Oklahoma City
Show 2 more studies
Weight-loss study of cagrilintide
Where: Oklahoma City
What: Tests whether a study medicine from Novo Nordisk, cagrilintide, can help people lose weight.
Free to join
Who can join: Children and teens 8 to 18 who are overweight.
Study record on ClinicalTrials.gov
Children's Physicians OU, Oklahoma City
Weight-loss study of KAI-9531
Where: Norman
What: Tests whether an investigational medicine from Kailera, KAI-9531, can help people lose weight.
Free to join
Who can join: Adults 18+ with obesity, BMI 35+.
Study record on ClinicalTrials.gov
Kailera Clinical Site, Norman
Type 2 diabetes studies (3)
Type 2 diabetes study of semaglutide
Where: Oklahoma City
What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18+ with type 2 diabetes, BMI 23+.
Study record on ClinicalTrials.gov
Research Site, Oklahoma City
Type 2 diabetes study of survodutide
Where: Oklahoma City
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18+ with type 2 diabetes, BMI 23+.
Call the site: 833-602-2368Study record on ClinicalTrials.gov
Tekton Research Oklahoma City, Oklahoma City. 833-602-2368
Type 2 diabetes study of LY3457263
Where: Norman
What: Tests whether an investigational medicine from Lilly, LY3457263, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18 to 75 with type 2 diabetes, BMI 27+.
Call the site: 4057018999Study record on ClinicalTrials.gov
Alliance for Multispecialty Research, LLC, Norman. 4057018999
Other GLP-1 studies in Oklahoma (4)
Fatty liver disease with liver scarring study of survodutide
Where: Tulsa
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).
Call the site: 833-602-2368Study record on ClinicalTrials.gov
Options Health Research, Tulsa. 833-602-2368
Fatty liver disease (also called MASH or NASH) study of survodutide
Where: Tulsa
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.
Call the site: 833-602-2368Study record on ClinicalTrials.gov
Options Health Research, Tulsa. 833-602-2368
Prehypertension study of orforglipron
Where: Tulsa
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people with prediabetes lose weight.
Free to join
Who can join: Adults 18+ who are overweight, BMI 25+.
Call the site: 918-645-5400Study record on ClinicalTrials.gov
Central States Research, Tulsa. 918-645-5400
Show 1 more study
Tobacco use study of semaglutide
Where: Oklahoma City
What: Tests a GLP-1 medicine, semaglutide, in people trying to quit smoking.
Free to join
Who can join: Adults 18 to 65 who are trying to quit smoking, BMI 30+.
Call the site: 405-271-7759Study record on ClinicalTrials.gov
Health Promotion Research Center, Oklahoma City. 405-271-7759
Source: ClinicalTrials.gov, the federal registry, read October 2, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.
Clinical trials by state
Every state with a GLP-1 study recruiting today. 48 of them.
- Alabama (17)
- Arizona (22)
- Arkansas (6)
- California (51)
- Colorado (17)
- Connecticut (13)
- Delaware (1)
- District of Columbia (1)
- Florida (42)
- Georgia (23)
- Hawaii (5)
- Idaho (12)
- Illinois (30)
- Indiana (19)
- Iowa (10)
- Kansas (15)
- Kentucky (15)
- Louisiana (15)
- Maine (1)
- Maryland (22)
- Massachusetts (19)
- Michigan (20)
- Minnesota (18)
- Mississippi (6)
- Missouri (21)
- Montana (3)
- Nebraska (5)
- Nevada (13)
- New Hampshire (3)
- New Jersey (12)
- New Mexico (5)
- New York (30)
- North Carolina (30)
- North Dakota (5)
- Ohio (28)
- Oklahoma (12)
- Oregon (5)
- Pennsylvania (33)
- Rhode Island (6)
- South Carolina (24)
- South Dakota (2)
- Tennessee (26)
- Texas (56)
- Utah (14)
- Virginia (28)
- Washington (23)
- West Virginia (5)
- Wisconsin (7)
